Despite No Ties, Vivos Feels Heat from Widely Publicized Oral Appliance Lawsuit
Vivos Therapeutics reported a decline in product revenue and enrollments in the second quarter, a dip it attributed to governmental investigations into third parties offering non-FDA-approved sleep apnea treatments.